Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 220
Report Code : HC-1072
Blood Processing Equipment Market Introduction The global blood processing equipment market is assessed to value over US$ 49 billion by the end of 2027 and expand at a CAGR of over 7.5% during the forecast period of 2020-2027. The collection and processing of the entire blood sample is done using an automated blood processing equipment. The main purpose of using the whole blood sample is it can be used as source material for preparing blood components like White Blood Cells (WBC), Red Blood Cells (RBC), plasma platelets etc. It converts the entire blood sample into various components, mostly used for purposes like a blood transfusion. Key benefits of using automated blood processing equipment are shortening of the blood processing time by reduction of power and minimal contamination due to reduced human intervention. It also helps the blood banks and hospitals to enhance lab efficiency by optimizing throughput without burdening the lab. Automated blood processing, therefore, offers quick and efficient patient care due to all these factors. Other advantages of using this equipment are a reduction in the timings of emergency rooms as results obtained are obtained in no time and are reliable as well which is better than the traditional blood processing equipment. Blood Processing Equipment Market Overview: Changing lifestyles pattern among the general population tend to impact the quality of life and increased prevalence of metabolic diseases. Rising prevalence of metabolic diseases and growing traumatic injuries created a huge demand for blood transfusion and processing equipments. Further, the rising importance of processing equipment in the prevention of diseases transmissions boosted the growth. Processing equipments are an irreplaceable diagnostic tool for the prevention of infectious diseases which can directly affect the quality of life of individuals. Technological advancements have significantly improved the traditional equipment and led to the development of multiple modality equipments. Additional, changing government policies to encourage companies to advance the research programs by providing tax benefits and incentives led to robust growth of the market. Asia Pacific region dominated the global market due to the high prevalence of metabolic diseases and traumatic injuries. It is majorly dominated by China, Japan, and India due to the huge demand of processing equipment among the end user segment. It is followed by developed economies like North America and Europe regions. Both these regions are expected to witness slow growth rate due to market maturation with major players. Latin America and Rest of World is fast growing regions due to increasing adoption and changing government policies. They are expected to remain the same throughout the forecast period. Blood Processing Equipment market players include SARSTEDT AG & Co. KG, Becton Dickinson, Medtronic, Terumo Corp, Greiner Bio-One International GmbH and others. Blood Processing Equipment Market Segmentation: By Product Type Blood Bank Freezers/Refrigerators Blood Cell Processors Hematocrit Centrifuges Blood collection consumables and supplies By End User Hospitals Blood Banks Blood Component Suppliers Clinics Outpatient Centres By Region North America Latin America Europe Asia Pacific Rest of the World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global Blood Processing Equipment Market by Product Type, by End-User, by Region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies.
The global blood processing equipment market is assessed to value over US$ 49 billion by the end of 2027 and expand at a CAGR of over 7.5% during the forecast period of 2020-2027.
The collection and processing of the entire blood sample is done using an automated blood processing equipment. The main purpose of using the whole blood sample is it can be used as source material for preparing blood components like White Blood Cells (WBC), Red Blood Cells (RBC), plasma platelets etc. It converts the entire blood sample into various components, mostly used for purposes like a blood transfusion. Key benefits of using automated blood processing equipment are shortening of the blood processing time by reduction of power and minimal contamination due to reduced human intervention. It also helps the blood banks and hospitals to enhance lab efficiency by optimizing throughput without burdening the lab. Automated blood processing, therefore, offers quick and efficient patient care due to all these factors. Other advantages of using this equipment are a reduction in the timings of emergency rooms as results obtained are obtained in no time and are reliable as well which is better than the traditional blood processing equipment.
Blood Processing Equipment Market Overview:
Changing lifestyles pattern among the general population tend to impact the quality of life and increased prevalence of metabolic diseases. Rising prevalence of metabolic diseases and growing traumatic injuries created a huge demand for blood transfusion and processing equipments. Further, the rising importance of processing equipment in the prevention of diseases transmissions boosted the growth. Processing equipments are an irreplaceable diagnostic tool for the prevention of infectious diseases which can directly affect the quality of life of individuals. Technological advancements have significantly improved the traditional equipment and led to the development of multiple modality equipments. Additional, changing government policies to encourage companies to advance the research programs by providing tax benefits and incentives led to robust growth of the market.
Asia Pacific region dominated the global market due to the high prevalence of metabolic diseases and traumatic injuries. It is majorly dominated by China, Japan, and India due to the huge demand of processing equipment among the end user segment. It is followed by developed economies like North America and Europe regions. Both these regions are expected to witness slow growth rate due to market maturation with major players. Latin America and Rest of World is fast growing regions due to increasing adoption and changing government policies. They are expected to remain the same throughout the forecast period.
Blood Processing Equipment market players include SARSTEDT AG & Co. KG, Becton Dickinson, Medtronic, Terumo Corp, Greiner Bio-One International GmbH and others.
Blood Processing Equipment Market Segmentation:
By Product Type
By End User
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Blood Processing Equipment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Blood Processing Equipment Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Blood Processing Equipment Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Blood Processing Equipment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Blood Processing Equipment Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Blood Bank Freezers/Refrigerators 7.2. Blood Cell Processors 7.3. Hematocrit Centrifuges 7.4 Blood collection consumables and supplies 8. Global Blood Processing Equipment Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hospitals 8.2. Blood Banks 8.3. Blood Component Suppliers 8.4. Clinics 8.5. Outpatient Centres 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. SARSTEDT AG & Co. KG 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Becton Dickinson 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Medtronic 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Terumo Corp 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Greiner Bio-One International GmbH 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data
2.1.1. Secondary Data
2.1.1.1. Key Data from Secondary Sources
2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation
2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Blood Processing Equipment Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Blood Processing Equipment Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Blood Processing Equipment Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Blood Processing Equipment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Blood Processing Equipment Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Blood Bank Freezers/Refrigerators
7.2. Blood Cell Processors
7.3. Hematocrit Centrifuges
7.4 Blood collection consumables and supplies
8. Global Blood Processing Equipment Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Hospitals
8.2. Blood Banks
8.3. Blood Component Suppliers
8.4. Clinics
8.5. Outpatient Centres
9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
9.1. Introduction
9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
9.2.1. U.S.A
9.2.2. Canada
9.2.3. Mexico
9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
10.2.1. Brazil
10.2.2. Venezuela
10.2.3. Argentina
10.2.4. Rest of Latin America
10.3. Market Size (USD Million) Forecast for Latin America 2020-2027
11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
11.2.1. Germany
11.2.2. U.K
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Poland
11.2.8. Rest of Europe
11.3. Market Size (USD Million) Forecast for Europe 2020-2027
12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
12.2.1. Japan
12.2.2. China
12.2.3. India
12.2.4. Australia and New Zealand
12.2.5. ASEAN
12.2.6. Rest of Asia Pacific
12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Saudi Arabia
13.2.2. UAE
13.2.3. South Africa
13.2.4. Egypt
13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
14.1. SARSTEDT AG & Co. KG
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.3. SWOT Analysis
14.1.4. Financial Overview
14.1.5. Strategic Overview
14.2. Becton Dickinson
14.2.1. Company Overview
14.2.2. Product Portfolio
14.2.3. SWOT Analysis
14.2.4. Financial Overview
14.2.5. Strategic Overview
14.3. Medtronic
14.3.1. Company Overview
14.3.2. Product Portfolio
14.3.3. SWOT Analysis
14.3.4. Financial Overview
14.3.5. Strategic Overview
14.4. Terumo Corp
14.4.1. Company Overview
14.4.2. Product Portfolio
14.4.3. SWOT Analysis
14.4.4. Financial Overview
14.4.5. Strategic Overview
14.5 Greiner Bio-One International GmbH
14.5.1. Company Overview
14.5.2. Product Portfolio
14.5.3. SWOT Analysis
14.5.4. Financial Overview
14.5.5. Strategic Overview
15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics